Genetic analysis of breast cancer progression
- PMID: 10887488
- DOI: 10.1007/BF02013638
Genetic analysis of breast cancer progression
Abstract
At the histological level, breast tumors display a variety of morphologic lesions which suggest the existence of an increasingly aberrant pathway of intermediate steps leading to the invasive primary tumor and its metastatic dissemination. In order to obtain direct evidence for this presumed progression, underlying genetic changes must be identified. Analyses of primary breast tumors have revealed a large number of dominant and recessive gene alterations encompassing several cellular attributes and activities. It is quite likely that some of these alterations are of a causal nature and thus enable the tumor to attain distinctive malignant phenotypes, such as, dysregulated proliferation, invasion, angiogenesis, and ability to metastasize. Considerable heterogeneity has been observed in the sequence of acquisition of these genetic changes, which is substantiated by recent comparative analyses between carefully microdissected preinvasive and invasive tumor. The data are evaluated here in the context of existing models of breast cancer progression. Implication and prospects for translational application to the clinic are also discussed.
Similar articles
-
Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.Breast Cancer Res. 2015 Jul 25;17(1):98. doi: 10.1186/s13058-015-0607-y. Breast Cancer Res. 2015. PMID: 26208975 Free PMC article.
-
Differentially expressed genes associated with the metastatic phenotype in breast cancer.Breast Cancer Res Treat. 1999 May;55(2):127-36. doi: 10.1023/a:1006188129423. Breast Cancer Res Treat. 1999. PMID: 10481940
-
Metastatic suppressor CD44 is related with oxidative stress in breast cancer cell lines.Int J Oncol. 2011 Dec;39(6):1481-9. doi: 10.3892/ijo.2011.1154. Epub 2011 Aug 9. Int J Oncol. 2011. PMID: 21833471
-
Deciphering the molecular basis of breast cancer metastasis with mouse models.Rev Endocr Metab Disord. 2007 Sep;8(3):199-213. doi: 10.1007/s11154-007-9041-5. Rev Endocr Metab Disord. 2007. PMID: 17657606 Review.
-
Gene expression sigantures, cancer cell evolution and metastatic progression.Cell Cycle. 2004 Jan;3(1):29-31. Cell Cycle. 2004. PMID: 14657660 Review.
Cited by
-
Modeling the effect of tumor size in early breast cancer.Ann Surg. 2005 Feb;241(2):309-18. doi: 10.1097/01.sla.0000150245.45558.a9. Ann Surg. 2005. PMID: 15650642 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical